Sora Investors LLC Purchases 362,245 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Sora Investors LLC lifted its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 289.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 487,245 shares of the construction company's stock after buying an additional 362,245 shares during the period. Sora Investors LLC owned about 0.59% of Aspen Aerogels worth $5,788,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Point72 Asset Management L.P. acquired a new position in shares of Aspen Aerogels during the fourth quarter worth about $13,122,000. ProShare Advisors LLC boosted its position in shares of Aspen Aerogels by 57.9% during the fourth quarter. ProShare Advisors LLC now owns 17,386 shares of the construction company's stock worth $207,000 after buying an additional 6,376 shares during the period. Oaktop Capital Management II L.P. boosted its position in Aspen Aerogels by 5.6% during the fourth quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock valued at $44,437,000 after purchasing an additional 200,000 shares during the last quarter. Maven Securities LTD boosted its position in Aspen Aerogels by 100.0% during the fourth quarter. Maven Securities LTD now owns 30,000 shares of the construction company's stock valued at $356,000 after purchasing an additional 15,000 shares during the last quarter. Finally, Needham Investment Management LLC boosted its position in Aspen Aerogels by 5.2% during the fourth quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company's stock valued at $28,390,000 after purchasing an additional 117,500 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the stock in a transaction dated Monday, May 12th. The stock was purchased at an average cost of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer now owns 550,856 shares in the company, valued at approximately $2,947,079.60. The trade was a 3.77% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 4.30% of the company's stock.

Aspen Aerogels Trading Down 2.1%

ASPN traded down $0.13 during midday trading on Monday, hitting $6.21. 2,565,297 shares of the company were exchanged, compared to its average volume of 1,967,577. The firm's 50 day moving average price is $5.89 and its 200-day moving average price is $10.02. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $509.87 million, a P/E ratio of 38.81 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm had revenue of $78.72 million during the quarter, compared to analyst estimates of $82.75 million. During the same period last year, the company posted ($0.02) EPS. The business's quarterly revenue was down 16.7% on a year-over-year basis. As a group, equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Craig Hallum lowered their price objective on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. Finally, Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.11.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.